1 Study Coverage
1.1 In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Introduction
1.2 Global In-vitro Diagnostic Services Outlook 2017 VS 2022 VS 2028
1.2.1 Global In-vitro Diagnostic Services Market Size for the Year 2017-2028
1.2.2 Global In-vitro Diagnostic Services Market Size for the Year 2017-2028
1.3 In-vitro Diagnostic Services Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States In-vitro Diagnostic Services in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of In-vitro Diagnostic Services Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 In-vitro Diagnostic Services Market Dynamics
1.4.1 In-vitro Diagnostic Services Industry Trends
1.4.2 In-vitro Diagnostic Services Market Drivers
1.4.3 In-vitro Diagnostic Services Market Challenges
1.4.4 In-vitro Diagnostic Services Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 In-vitro Diagnostic Services by Type
2.1 In-vitro Diagnostic Services Market Segment by Type
2.1.1 Infectious Testing
2.1.2 Diabetes Testing
2.1.3 Molecular Testing
2.1.4 Tissue Testing
2.2 Global In-vitro Diagnostic Services Market Size by Type (2017, 2022 & 2028)
2.3 Global In-vitro Diagnostic Services Market Size by Type (2017-2028)
2.4 United States In-vitro Diagnostic Services Market Size by Type (2017, 2022 & 2028)
2.5 United States In-vitro Diagnostic Services Market Size by Type (2017-2028)
3 In-vitro Diagnostic Services by Application
3.1 In-vitro Diagnostic Services Market Segment by Application
3.1.1 Hospitals
3.1.2 Point-Of-Care Testing
3.1.3 Laboratories
3.1.4 Academic Institutes
3.2 Global In-vitro Diagnostic Services Market Size by Application (2017, 2022 & 2028)
3.3 Global In-vitro Diagnostic Services Market Size by Application (2017-2028)
3.4 United States In-vitro Diagnostic Services Market Size by Application (2017, 2022 & 2028)
3.5 United States In-vitro Diagnostic Services Market Size by Application (2017-2028)
4 Global In-vitro Diagnostic Services Competitor Landscape by Company
4.1 Global In-vitro Diagnostic Services Market Size by Company
4.1.1 Top Global In-vitro Diagnostic Services Companies Ranked by Revenue (2021)
4.1.2 Global In-vitro Diagnostic Services Revenue by Player (2017-2022)
4.2 Global In-vitro Diagnostic Services Concentration Ratio (CR)
4.2.1 In-vitro Diagnostic Services Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of In-vitro Diagnostic Services in 2021
4.2.3 Global In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global In-vitro Diagnostic Services Headquarters, Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Type
4.3.1 Global In-vitro Diagnostic Services Headquarters and Area Served
4.3.2 Global In-vitro Diagnostic Services Companies Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into In-vitro Diagnostic Services Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States In-vitro Diagnostic Services Market Size by Company
4.5.1 Top In-vitro Diagnostic Services Players in United States, Ranked by Revenue (2021)
4.5.2 United States In-vitro Diagnostic Services Revenue by Players (2020, 2021 & 2022)
5 Global In-vitro Diagnostic Services Market Size by Region
5.1 Global In-vitro Diagnostic Services Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global In-vitro Diagnostic Services Market Size by Region (2017-2028)
5.2.1 Global In-vitro Diagnostic Services Market Size by Region: 2017-2022
5.2.2 Global In-vitro Diagnostic Services Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America In-vitro Diagnostic Services Market Size YoY Growth 2017-2028
6.1.2 North America In-vitro Diagnostic Services Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 Asia-Pacific
6.2.1 Asia-Pacific In-vitro Diagnostic Services Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific In-vitro Diagnostic Services Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe In-vitro Diagnostic Services Market Size YoY Growth 2017-2028
6.3.2 Europe In-vitro Diagnostic Services Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America In-vitro Diagnostic Services Market Size YoY Growth 2017-2028
6.4.2 Latin America In-vitro Diagnostic Services Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa In-vitro Diagnostic Services Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa In-vitro Diagnostic Services Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 BioRad
7.1.1 BioRad Company Details
7.1.2 BioRad Business Overview
7.1.3 BioRad In-vitro Diagnostic Services Introduction
7.1.4 BioRad Revenue in In-vitro Diagnostic Services Business (2017-2022)
7.1.5 BioRad Recent Development
7.2 DexCom
7.2.1 DexCom Company Details
7.2.2 DexCom Business Overview
7.2.3 DexCom In-vitro Diagnostic Services Introduction
7.2.4 DexCom Revenue in In-vitro Diagnostic Services Business (2017-2022)
7.2.5 DexCom Recent Development
7.3 Nova Biomedical
7.3.1 Nova Biomedical Company Details
7.3.2 Nova Biomedical Business Overview
7.3.3 Nova Biomedical In-vitro Diagnostic Services Introduction
7.3.4 Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2017-2022)
7.3.5 Nova Biomedical Recent Development
7.4 OraSure
7.4.1 OraSure Company Details
7.4.2 OraSure Business Overview
7.4.3 OraSure In-vitro Diagnostic Services Introduction
7.4.4 OraSure Revenue in In-vitro Diagnostic Services Business (2017-2022)
7.4.5 OraSure Recent Development
7.5 Pearl Pathways
7.5.1 Pearl Pathways Company Details
7.5.2 Pearl Pathways Business Overview
7.5.3 Pearl Pathways In-vitro Diagnostic Services Introduction
7.5.4 Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2017-2022)
7.5.5 Pearl Pathways Recent Development
7.6 Phenomenex
7.6.1 Phenomenex Company Details
7.6.2 Phenomenex Business Overview
7.6.3 Phenomenex In-vitro Diagnostic Services Introduction
7.6.4 Phenomenex Revenue in In-vitro Diagnostic Services Business (2017-2022)
7.6.5 Phenomenex Recent Development
7.7 Qiagen
7.7.1 Qiagen Company Details
7.7.2 Qiagen Business Overview
7.7.3 Qiagen In-vitro Diagnostic Services Introduction
7.7.4 Qiagen Revenue in In-vitro Diagnostic Services Business (2017-2022)
7.7.5 Qiagen Recent Development
7.8 Roche Diagnostics
7.8.1 Roche Diagnostics Company Details
7.8.2 Roche Diagnostics Business Overview
7.8.3 Roche Diagnostics In-vitro Diagnostic Services Introduction
7.8.4 Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2017-2022)
7.8.5 Roche Diagnostics Recent Development
7.9 Siemens
7.9.1 Siemens Company Details
7.9.2 Siemens Business Overview
7.9.3 Siemens In-vitro Diagnostic Services Introduction
7.9.4 Siemens Revenue in In-vitro Diagnostic Services Business (2017-2022)
7.9.5 Siemens Recent Development
7.10 Sysmex
7.10.1 Sysmex Company Details
7.10.2 Sysmex Business Overview
7.10.3 Sysmex In-vitro Diagnostic Services Introduction
7.10.4 Sysmex Revenue in In-vitro Diagnostic Services Business (2017-2022)
7.10.5 Sysmex Recent Development
7.11 Thermofisher
7.11.1 Thermofisher Company Details
7.11.2 Thermofisher Business Overview
7.11.3 Thermofisher In-vitro Diagnostic Services Introduction
7.11.4 Thermofisher Revenue in In-vitro Diagnostic Services Business (2017-2022)
7.11.5 Thermofisher Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
